Novel Targets for Alzheimer’s Disease Treatment: Medin and PLD3
Given that Alzheimer's disease is multifactorial and heterogenous, drug development progress is more likely to occur if multiple pathways are considered. Two recent Nature publications have potentially identified medin and PLD3 as new targets for Alzheimer’s disease treatment, which we summarize in this mini-review.
Alzheimer’s & Brain Awareness Month 2020
Image source: Alzheimer’s Association @alzassociation June is Alzheimer’s and Brain Awareness Month! At InsideScientific, we are proud to [...]
JUNE is Alzheimer’s and Brain Awareness Month!
Worldwide, more than 50 million people are living with Alzheimer’s Disease and other dementias. This month, you can join the [...]